BC risk management interventions targeting germline BRCA1 and BRCA2 pathogenic variant carriers include intensive BC screening for early detection and risk-reducing surgery (ie, prophylactic mastectomy).5-10 On one hand, screening using magnetic resonance imaging (MRI) shows high sensitivity and specificity in high-risk populations.8,9 On the other hand, it is essential to ensure that women attend their screening appointments regularly and punctually. This evidence concerns the gene BRCA2 and breast cancer.